[Federal Register Volume 76, Number 95 (Tuesday, May 17, 2011)]
[Notices]
[Pages 28442-28443]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2011-12046]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
Office of the Director, National Institutes of Health; Notice of
Meeting
Pursuant to section 10(a) of the Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is hereby given of a meeting of the
Recombinant DNA Advisory Committee.
The meeting will be open to the public, with attendance limited to
space available. Individuals who plan to attend and need special
assistance, such as sign language interpretation or other reasonable
accommodations, should notify the Contact Person listed below in
advance of the meeting.
Name of Committee: Recombinant DNA Advisory Committee.
Date: June 7-9, 2011.
Time: June 7, 2011, 11 a.m. to 5:45 p.m.
Agenda: The NIH Recombinant DNA Advisory Committee (RAC) will
review and discuss selected human gene transfer protocols, and
discuss related data management activities as well as a review of
biocontainment for experiments with a defective Lassa virus. Please
check the meeting agenda at http://oba.od.nih.gov/rdna_rac/rac_meetings.html for more information.
Place: Bethesda Marriott Suites, 6711 Democracy Boulevard,
Bethesda, MD 20817.
Time: June 8, 2011, 8 a.m. to 5:35 p.m.
Agenda: The NIH Recombinant DNA Advisory Committee (RAC) will
review and discuss selected human gene transfer protocols, including
a protocol for severe obesity in subjects who either have a mutation
in the melanocortin 4 receptor or Prader-Willi syndrome, and discuss
related data management activities. Please check the meeting agenda
at http://oba.od.nih.gov/rdna_rac/rac_meetings.html for more
information.
Place: Bethesda Marriott Suites, 6711 Democracy Boulevard,
Bethesda, MD 20817.
Time: June 9, 2011, 8 a.m. to 11:15 a.m.
Agenda: The NIH Recombinant DNA Advisory Committee (RAC) will
review and discuss selected human gene transfer protocols, and
discuss related data management activities including proposed
revisions to the NIH Guidelines for Research with Recombinant DNA
Molecules for work with partial viral genomes in tissue culture
(Section III-E-1). Please check the meeting agenda at http://oba.od.nih.gov/rdna_rac/rac_meetings.html.
Place: Bethesda Marriott Suites, 6711 Democracy Boulevard,
Bethesda, MD 20817.
Contact Person: Chezelle George, Office of Biotechnology
Activities, Office of Science Policy/OD, National Institutes of
Health, 6705 Rockledge Drive, Room 750, Bethesda, MD 20892, 301-496-
9838, [email protected].
Information is also available on the Institute's/Center's home
page: http://oba.od.nih.gov/rdna/rdna.html, where an agenda and any
additional information for the meeting will be posted when
available.
OMB's ``Mandatory Information Requirements for Federal Assistance
Program Announcements'' (45 FR 39592, June 11, 1980) requires a
statement concerning the official government programs contained in
the Catalog of Federal Domestic Assistance. Normally NIH lists in
its announcements the number and title of affected individual
programs for the guidance of the public. Because the guidance in
this notice covers virtually every NIH and Federal research program
in which DNA recombinant molecule techniques could be used, it has
been determined not to be cost effective or in the public interest
to attempt to list these programs. Such a list would likely require
several additional pages. In addition, NIH could not be certain that
every Federal program would be included as many Federal agencies, as
well as private organizations, both national and international, have
elected to follow the NIH Guidelines. In lieu of the individual
program listing, NIH invites
[[Page 28443]]
readers to direct questions to the information address above about
whether individual programs listed in the Catalog of Federal
Domestic Assistance are affected.
(Catalogue of Federal Domestic Assistance Program Nos. 93.14,
Intramural Research Training Award; 93.22, Clinical Research Loan
Repayment Program for Individuals from Disadvantaged Backgrounds;
93.232, Loan Repayment Program for Research Generally; 93.39,
Academic Research Enhancement Award; 93.936, NIH Acquired
Immunodeficiency Syndrome Research Loan Repayment Program; 93.187,
Undergraduate Scholarship Program for Individuals from Disadvantaged
Backgrounds, National Institutes of Health, HHS)
Dated: May 10, 2011.
Jennifer S. Spaeth,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. 2011-12046 Filed 5-16-11; 8:45 am]
BILLING CODE 4140-01-P